In this special ECD 网络研讨会, Dr. Jerome Razanamahery, an internal medicine doctor at Dijon University Hospital, an ECD referral care center, talks about Erdheim-Chester Disease (ECD). He explains what ECD is, why it can be hard to 诊断, and how new targeted 治疗方法 are helping improve patient outcomes.
This 网络研讨会 is presented in French.
This video includes a message from Prof. Julien Haroche, a lead physician at the ECD referral care center at Hôpital Pitié-Salpêtrière in Paris, France. He is the head of the French Reference Center for Histiocytosis.
The video also features a powerful patient story from Mr. Jacques Dutu, who bravely shares his journey with ECD, from feelings of anger and confusion to hope and empowerment.
You’ll learn:
- What makes ECD a rare and complex inflammatory blood cancer
- Why ECD is hard to 诊断 early, and which 症状 to look out for
- How mutations like BRAFV600E affect treatment choices
- How targeted 治疗方法, such as BRAF and MEK inhibitors, help patients
- Why mental health support and quality of life are important
- Why the ECD全球联盟 exists and how it helps patients and families worldwide
This video is part of our ongoing mission to raise awareness, offer support, and help advance research for people affected by 埃尔德海姆-切斯特病。.